Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.00
+0.41 (2.21%)
At close: Mar 9, 2026, 4:00 PM EDT
19.03
+0.03 (0.16%)
After-hours: Mar 9, 2026, 4:17 PM EDT
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.37 billion as of March 9, 2026.
Market Cap
5.37B
Enterprise Value
5.00B
1-Year Change
n/a
Ranking
Category
Stock Price
$19.00
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.37B, a decrease of -9.83%. That is a compound annual growth rate of -13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.25B | -30.99% |
| Dec 31, 2025 | 7.61B | 27.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 5.88B |
| Immunovant | 5.43B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| CG Oncology | 5.22B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |
| PTC Therapeutics | 5.20B |